|
|
(Inside Asia Today Saturday 24 September 2016)
Apps that promote nip-tuck ops raise concerns in China
Since last year, Chinese venture capitalists and Internet giants have poured billions of yuan into mobile apps that offer heavy discounts and even huge loans to those who want to go under the cosmetic surgeon’s knife in a bid to improve their looks.
Such treatments occupy a grey area between healthcare and aesthetic treatments that has grown rapidly, but is barely regulated in China.
Several investors interviewed by Caixin said that compared to the healthcare sector, the cosmetic-surgery industry “faced fewer policy bottlenecks” in terms of surgery standards, drug prescription rules and medical insurance requirements, paving the way for faster growth and making it more predictable for investors.
But the widespread practices of paying for reviews and offering easy access to loans of up to hundreds of thousands of yuan have caused concern about the business practices of these fledgling nip-tuck apps, and the lack of regulations to rein in the booming cosmetic-surgery industry.
Since 2014, apps and websites that make it easier for customers to connect with plastic surgeons have mushroomed in the country.
A college freshman who uses the nickname “Xiao Bai” had used two popular apps — SoYoung and Gengmei, or “more beautiful” in Chinese — and said they looked like a mishmash of Facebook and Yelp, with features to rate clinics and treatments, and make friends with those who have already undergone surgery.
“I was surprised at how closely the apps resembled a social network, or perhaps a self-improvement blog,” the 20-year-old said.
Carefully snapped “before and after” selfies from cosmetic surgery enthusiasts — mostly women in their teens and 20s — fill the home page of Gengmei, along with short journal entries detailing patients’ experiences with treatments. The comments sections are filled with gushing praise — “So pretty!” “How cute!” “You’ve really recovered quickly!”
In early August, Wanmei Chuangyi Technology, the Beijing-based startup that created Gengmei, raised 345 million yuan (S$70.4 million) in its third round of fundraising. Internet heavyweight Tencent Holdings invested US$50 million (S$68 million) in Gengmei’s major rival, SoYoung Technology (Beijing), valued at 3 billion yuan, in May.
Other start-ups vying for a piece of the beauty pie have raked in millions of yuan from investors, including Suning Universal, Shanghai Fosun Pharma Group, and Alibaba Group.
The Chinese Association of Plastics and Aesthetics, a nonprofit industry association, said that demand for cosmetic surgery in China is expected to more than double to 800 billion yuan by 2019 from the amount spent in 2014, making the country the world’s third-largest plastic-surgery market after the United States and Brazil.
Growing incomes, especially among women, plus peer pressure and the “tremendous influence” of South Korean pop culture have fuelled the demand for “better looks”, wrote Wang Yumeng, a healthcare analyst for HSBC Global Research, in a February report.
SoYoung in May said nearly 60,000 non-invasive treatments are booked each month through its app. The company running Gengmei said the app had attracted over 15 million registered users since it made its debut in 2013, and it offers services from over 6,000 clinics.
Clinics are lining up to advertise their services on these apps because they are a cheaper way to find clients. Before, it cost clinics an average of 6,000 yuan to attract a client via advertising services provided by search engine Baidu, but mobile apps have cut this to a few hundred yuan, said Liu Di, founder and chief executive of Gengmei.
But a Caixin intern found that many of the clinics listed on these apps do not provide any evidence of a government licence or accreditation, and some clinics paid users for reviews.
“Users earn ‘beauty points’, which can be traded in for discounts, by sharing their personal experiences or leaving comments on others’ posts,” Ms Xiao Bai said. Customers can also earn discounts by sharing promotional material from Gengmei on the widely used social networking app, WeChat.
“On some apps, it literally pays to participate,” she said.
Several apps also allow cosmetic surgery enthusiasts to apply for low-interest loans to fund their treatments. “Through SoYoung Wallet, a college student like me can easily receive thousands of yuan in loans to go under the knife,” Ms Xiao Bai said.
A quick glance at SoYoung’s “Wallet” feature shows it allows users to borrow up to 6,000 yuan at a 1.2 per cent interest rate or take out large loans of up to 200,000 yuan at an interest rate of 1 per cent, but the timeline for repayment was not immediately clear. The app claims that 70 to 80 per cent of all loan applications are approved, and one needs only to provide rudimentary personal information such as their employment and educational backgrounds and upload a salary stub to take out the loan.
“The ease with which a young person like me with no credit history and little understanding of debt can borrow money worries me,” Ms Xiao Bai said.
BEAUTY BUSINESS
Internet start-ups betting on China’s widespread fetish for double eyelids, a high nose bridge and a narrower jawline share a similar business model.
Many rely on building “a community” where users rate clinics and doctors, and share their treatment experiences as a way to bridge the trust gap that exists in the industry.
In China, plastic surgeons must have a government licence, but only an associate’s degree is required, according to the Asian Plastic Surgery Guide. Accreditation requirements for clinics are vague.
There are about 4,000 plastic surgery clinics in the country, including 500 operated by public hospitals and 500 larger, private clinical chains, China International Capital Corp said.
There are another 3,000 small and medium-sized private clinics, and there have been frequent customer complaints to the official consumer welfare watchdog against the smaller players, citing botched operations and questionable deals, the investment bank said.
Carefully snapped ‘before and after’ selfies from cosmetic surgery enthusiasts and journal entries detailing their experiences fill Gengmei’s home page.
BY THE NUMBERS 60,000
Non-invasive treatments are booked each month through SoYoung’s app, said the company in May.
Recently, prosecutors in the eastern city of Nanjing said that 23 suspects were facing criminal charges for running unlicensed plastic surgery clinics in the city. Many users now rely on “friend’s recommendations” when selecting a clinic, an analyst said, and mobile apps try to tap this trend.
“By creating an online community for patients to share their experiences and rate clinics, beauty service apps are becoming trustworthy sources of information that help consumers make better choices,” said Liu Xiao, vice-president of SoYoung. But he did not comment on the practice of offering redeemable “beauty points” for diary entries, comments and spreading the word about deals among friends, a widespread practice among apps that many see as comparable to paying for testimonials and reviews.
Cosmetic surgery apps get a commission from clinics for allowing users to consult with a surgeon online, make appointments or book a surgery, and use steep discounts to attract clients.
“Plastic surgery apps are mainly luring users through heavily discounted deals,” said Ma Dongsheng, deputy general manager of Evercare (Beijing) Holding Group, a leading cosmetic clinics chain.
This practice creates a problem for clinics because customers who book services through mobile apps are more price-sensitive and it is difficult to transform them into long-term clients who may opt for other procedures, he said. Large plastic surgery hospitals are reluctant to partner with apps for this reason, he added.
Users say some apps cut treatment prices by nearly two-thirds. “When I prepared to book a double-eyelid surgery at a clinic in downtown Beijing, I had to pay a 399-yuan deposit for a procedure that would cost about 2,000 yuan after the discount offered by the app. But when I visited the same clinic in person, the attending doctor said the actual surgery price started at 6,800 yuan,” Ms Xiao Bai said.
Data on how these discount deals for treatments are affecting consumer choices, especially whether they may lead to a form of surgery addiction, is not available, because many of the start-ups are only two to three years old.
A SHOT IN THE ARM
Several medical industry investors said the discount-driven business model may hinder the future growth of plastic surgery apps.
But Gengmei founder Mr Liu said apps are moving away from commissions and diversifying their revenue streams into advertising and selling drugs and supplements needed for post-surgery care, and even connecting clinics with material and equipment suppliers. Apps also want to make money by offering loans to clients, he said.
According to Mr Liu, the most lucrative part of the plastic surgery industry is selling drugs and materials, where mark-ups are high.
Industry information provider Cnii.com.cn says about 820,000 Botox injections were sold in China last year, at prices ranging from 4,000 yuan to 7,000 yuan. But about half of the injections were fake products or smuggled into the country, so their supply source was unknown, the website said.
Beauty service apps can help clinics connect with drug and material suppliers, cutting out middlemen, and help control the quality of supplies, Mr Liu said.
But difficulties in getting drugselling licences, and the high cost of developing storage and transportation facilities for drugs such as Botox, have delayed these plans, Evercare’s Mr Ma said.
Cosmetic surgery apps are also eyeing plans to expand into running offline clinics. In June, SoYoung opened its first brickand-mortar clinic in Beijing, offering minor treatments. In August, Gengmei announced a plan to build hospitals and train 100 surgeons. The two companies said they may turn a profit by the end of this year after bleeding cash for three years.
A cosmetic surgery industry investor, however, said he was switching his investment focus from brick-and-mortar clinics to mobile platforms because the latter had a lower investment threshold and better potential for faster growth. CAIXIN
